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Abstract We report the isolation of a cDNA encoding a novel
murine serine proteinase, epitheliasin. The cDNA spans 1753 bp
and encodes a mosaic protein with a calculated molecular mass of
53 529 Da. Its domains include a cytoplasmic tail, a type II
transmembrane domain, a low-density lipoprotein receptor class
A domain, a cysteine rich scavenger receptor-like domain and a
serine proteinase domain. The proteinase portion domain shows
46^53% identity with mouse neurotrypsin, acrosin, hepsin and
enteropeptidase. The gene, located in the telomeric region in the
long arm of mouse chromosome 16, consists of 14 exons and 13
introns and spans approximately 18 kb. Epitheliasin is expressed
primarily in the apical surfaces of renal tubular and airway
epithelial cells.
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1. Introduction
Proteinases are implicated in a wide spectrum of physio-
logic and pathophysiological processes in the kidney. Renin,
a proteinase synthesized in renal cortical cells plays a major
role in the regulation of blood pressure and electrolyte bal-
ance by converting angiotensinogen to angiotensin I. Further-
more, the renal kallikrein-kinin system activated under con-
ditions of mineralocorticoid excess represents a compensatory
response against the development of hypertension and renal
injury induced by salt excess. Proteolytic enzymes also have
been ascribed important roles in both leukocyte-dependent
and independent models of glomerular diseases (reviewed in
[1]). Recently, Vallet and colleagues identi¢ed a novel serine
proteinase from Xenopus laevis kidney epithelial cells, CAP 1,
involved in activation of the epithelial sodium channel, EnaC
[2]. This was the ¢rst report of channel activating activity of
an endogenous proteinase.
In the present report, we describe a novel serine proteinase
expressed in murine renal epithelial cells with sequence homol-
ogy to CAP1. The enzyme, that we term epitheliasin, is a
modular protein consisting of ¢ve sequence motifs, a cytoplas-
mic tail, a type II transmembrane (TM) domain, a low-density
lipoprotein receptor class A (LDLRA)-like domain, a cysteine
rich scavenger receptor-like (SRCR) domain and a serine pro-
teinase domain. The sequence and structural features of epi-
theliasin cDNA and gene, its chromosomal localization and
tissue expression are described. Epitheliasin has sequence
identity to a human cDNA recently cloned by exon trapping
named TMPRSS2 [3]. However, the tissue distribution of epi-
theliasin and TMPRSS2 is strikingly di¡erent.
2. Materials and methods
2.1. Materials
Multiple tissue Northern blots, ExpressHyb hybridization solution,
rapid ampli¢cation of cDNA ends (RACE) ready cDNAs from mouse
kidneys and Marathon cDNA kits were from CLONTECH (Palo
Alto, CA, USA). TA cloning kits were from Invitrogen (Carlsbad,
CA, USA). LA PCR kits were from Panvera (Madison, WI, USA).
Klenow DNA polymerase, [K-32P]dCTP (3000 Ci/mmol) and [Q-32P]-
dATP (3000 Ci/mmol) were from Amersham Life Science (Arlington
Heights, IL, USA). BUPH1 Tris^glycine SDS, Tris^glycine and Im-
munogen Conjugation kits were from Pierce (Rockford, IL, USA).
Alkaline phosphatase conjugated goat anti-rabbit antibody was
from Zymed (San Francisco, CA, USA). BCIP/NBT tablets were
from Sigma (St Louis, MO, USA). Citra solution and VIP substrate
were from Vector Laboratories (Burlingame, CA, USA). Blocking
reagent, SA-HRP and biotinyl tyramide were supplied by NEN Life
Science Products (Boston, MA, USA).
2.2. Identi¢cation and cloning of epitheliasin cDNA
A conserved sequence around the serine active site residue
(GGIDSCQGDSGGPLVC) was used to search the mouse EST data-
base using TBLASTn. Of the 100 ESTs initially identi¢ed, a novel
EST (ub58g01.s1) containing 389 nt and its mirror sequence
(ub58g01.r1) were further analyzed using the non-redundant data-
bases, BLASTn and BLASTx. Four overlapping sequences were
found from these searches, one was from a kidney library
(uc81c11.y1), two from a mammary gland library (vf86g09.r1,
ve37e12.r1), and one from a blastocyst library (v164c03.r1).
To obtain the full-length cDNA of interest the RACE strategy was
employed. Initially, LA PCR was utilized to amplify mouse kidney
cDNA employing a sense primer (5P-336CCATACTGAACTCCTC-
ATGCTGCT313-3P) designed based on the novel sequence and an
anchor primer, AP1. The initial PCR product was subjected to nested
PCR using a sense (5P-314CTGACACAGGCAGGATGGCATTG9-
3P) and an anti-sense primer (5P-1455GTGGATTAGCTGTTCGCC-
CTCATT1478-3P). This nested reaction ampli¢ed a 1.5 kb product
that was ligated into the pCR03.1 vector and sequenced using an
ABI automatic sequencer.
To obtain the 3P end, mouse kidney cDNA was subjected to 3P-
RACE. The cDNA was ampli¢ed using AP1 and a sense primer (5P-
336CCATACTGAACTCCTCATGCTGCT313-3P). The product was
diluted (1:50) and a nested PCR ampli¢cation was performed using
a second anchor primer, AP2, and a sense primer (5P-
314CTGACACA- GGCAGGATGGCATTG9-3P). The 2 kb PCR
product obtained was cloned and sequenced as described above.
2.3. Genomic cloning and analysis
To obtain the epitheliasin gene, a mouse genomic bacterial arti¢cial
chromosome (BAC) library (Genome Systems, St Louis, MO, USA)
was screened using a 0.7 kb probe extending from 831 to 1477 nt of
mouse epitheliasin cDNA. A single clone (BAC-24) was identi¢ed and
con¢rmed by sequencing to contain the entire epitheliasin gene. To
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identify the intron junction borders, DNA from BAC-24 was directly
sequenced using oligonucleotide primers de¢ned initially by the cDNA
sequences and subsequently by derived sequences. Southern analysis
was used to determine the size of the epitheliasin gene.
2.4. Chromosomal assignment
The plasmid clone (BAC-24) obtained from the genomic library was
used as a probe for chromosomal localization by £uorescence in situ
hybridization (FISH). The probe was nick translation-labeled with
biotin, hybridized to metaphase chromosomes and detected with
Cy-3-conjugated streptavidin. Chromosome spreads were prepared
by standard procedures and G-banded after trypsin treatment and
Wright’s staining. Hybridization and detection conditions on meta-
phase chromosomes were performed as previously described [4]. Probe
signals were detected with the Cy3 conjugate viewed using an epi£uor-
escence microscope. The £uorescence image was overlaid on the G-
banded image to localize the gene.
2.5. Northern blot analysis
Mouse multi-tissue blots containing 2 Wg of poly(A) RNA in each
lane were prehybridized for 1 h at 68‡C, then hybridized at 68‡C with
a 1.5 kb [K-32P]dCTP-labeled probe that represented the coding region
of the mouse epitheliasin cDNA. After low stringency washes, the
blots were washed at high stringency at 50‡C and autoradiographed.
2.6. Production of antibodies against epitheliasin
Rabbit polyclonal antiserum was raised to a synthetic peptide,
cS331HPNYDSKTKNND343, located in the serine proteinase region
of epitheliasin. The peptide was chosen based on predicted surface
hydrophilicity and antigenicity. The peptide was coupled to keyhole-
limpet hemocyanin. Subcutaneous injections were given to rabbits
with 100 Wg of conjugate that was emulsi¢ed in Freund’s complete
adjuvant and then boosted with the same amount of antigen in
Freund’s incomplete adjuvant at 2 week intervals until a titer of
s 1:4000 was obtained. The presence of anti-peptide antibodies was
assessed by dot blot analysis using the peptide linked to ovalbumin as
the antigen.
2.7. Immunohistology
Mouse kidneys and lungs were ¢xed in bu¡ered 10% formaldehyde,
and embedded in para⁄n. Sections were cut at 5 Wm depths, depara⁄-
nized and rehydrated. Following antigen retrieval performed with 1U
Citra solution in a microwave oven for 15 min at 700^900 W, the
samples were washed in PBS. Endogenous peroxidase activity was
blocked with 20% methanol and 3% H2O2 in PBS for 30 min at
room temperature. The tissue was permeated using 10% Triton X-
100 in PBS for 20 min at room temperature. Endogenous biotin
was blocked by Vector Block avidin solution for 30 min at room
temperature followed by Vector Blocking solution for 30 min at
room temperature. The sections were then incubated with epitheliasin
peptide anti-serum, dilution 1/500 in Block solution overnight at 4‡C
in a humid chamber. After washing with TNT, 1/500 horse anti-rabbit
IgG serum in TNT was applied for 30 min at room temperature. The
slides were then incubated with 1/100 SA-HRP in TNT for 30 min at
room temperature. The signal was ampli¢ed with biotinyl tyramide
for 5 min at room temperature. This was followed by a re-incubation
with 1/100 SA-HRP in TNT. The signal was visualized using VIP
substrate solution. The same process was applied to the slides used
as controls, but epitheliasin anti-serum was replaced by non-immune
rabbit serum.
3. Results and discussion
3.1. Cloning and analysis of the epitheliasin full-length cDNA
Fig. 1 shows the nucleic acid and deduced amino acid se-
quences of the complete cDNA reconstituted from the RACE
fragments. As demonstrated by the immunohistochemistry de-
scribed in a following section, the encoded protein is highly
expressed in epithelial tissue. Accordingly, we named the pro-
tein epitheliasin. The composite cDNA spans 1753 nt. A 5P
untranslated region (UTR) extends 100 nt. The ¢rst in-frame
ATG (1^3 nt) was assigned as the codon for the Met trans-
lation initiator since the sequence around this codon (AG-
GATGG) conforms to the Kozak consensus sequence for
mammalian protein biosynthesis [5]. A single open reading
frame begins with the ATG and extends 1470 nt. This is
followed by a stop codon, TAA (1471^1473 nt) and a 3P-
UTR of 152 nt, terminating in a poly(A)+tail of 28 nt. A
consensus polyadenylation site (ATTAAA, 1600^1605 nt) is
located 20 nt upstream of the poly (A)+tail.
3.2. Characteristics of the sequence and structural features of
epitheliasin
The open reading frame encodes a protein of 490 amino
acids with a calculated molecular mass of 53 529 kDa. Com-
parisons with sequences in GenBank, EMBL and SWISS-
PROT reveal that the epitheliasin cDNA encodes a multido-
main serine proteinase. A typical amino-terminal signal se-
quence is not present, but a hydrophobic region is present
near the amino terminus (Leu84 to Trp105). This 22 amino
acid region is £anked by charged amino acids (Lys and
Arg) and corresponds to a transmembrane domain [6]. Based
on the di¡erence in total charge between the 15-residue se-
quences on either side of the membrane-spanning domain
epitheliasin can be classi¢ed as a type II integral membrane-
bound protein [7,8] that has a cytosol facing amino-terminal
tail region consisting of 83 amino acids (Met1 to Ser83) and an
extracellular facing COOH-terminal modular region. The ab-
sence of a signal peptide and the presence of a transmembrane
domain in epitheliasin are analogous to homologous serine
proteinases, enteropeptidase, a key enzyme in digestion that
is responsible for the conversion of trypsinogen to trypsin [9],
hepsin, a membrane-associated proteinase involved in the for-
mation of thrombin on cell surfaces [10], and a recently de-
scribed human airway trypsin-like proteinase [11].
The predicted domain structure of epitheliasin is shown in
Fig. 2. A LDLRA domain extending from Cys112 to Cys147
and containing six cysteines follows the transmembrane do-
main. This domain motif is found in a number of proteins
that are functionally unrelated to the LDLR family, including
clotting proteinases and enteropeptidase. In each of these pro-
teins the domain is thought to function as a protein-binding
domain. The LDLRA domain in epitheliasin is similar to
other typical LDLRA domains that are about 40 amino acids
long and contain six cysteines [12]. The cysteines form intra-
domain bridges resulting in a cluster of negatively charged
residues in a single loop positioned for high a⁄nity binding
to positively charged sequences in LDLR ligands.
Following the LDLRA domain, an SRCR-like domain ex-
tends from va148 to Gly243. SRCR domains are classi¢ed into
two groups, group A and B according to the number of con-
served cysteine residues, six or eight, respectively [13]. In a
recent analysis, all but one of the 33 independent SRCR do-
mains that had been previously identi¢ed had six or eight
cysteines [14]. An unusual feature of this domain in epithelia-
sin is that it contains only four cysteines. These cysteine res-
idues in epitheliasin are completely conserved in positions
suggesting that the domain belongs to group A. The SRCR
domain that is closest to that in epitheliasin is present in
complement factor 1 (CF1), a serum proteinase that regulates
the complement cascade by cleaving C3b and C4b. CF1 con-
tains a single SRCR domain with ¢ve cysteines [13].
The function of SRCR domains is largely unknown. It
seems likely that most of these domains are involved in bind-
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ing to molecules on the cell surface or in the extracellular
space. Direct evidence supporting the idea that SRCR do-
mains mediate binding to other cell surface proteins or extra-
cellular proteins has recently been provided [14,15].
3.3. Features of serine proteinase domain
The proteinase domain begins with Ile254 and represents the
major domain (about 50%) of the encoded protein. The pre-
dicted molecular mass of the domain is 25 892 kDa. The do-
main contains all the major features common to the S1 family
of the chymotrypsin (or SA) clan of serine proteinases. The
residues contributing to the salient structural features in chy-
motrypsin include: (1) His57, Asp102, and Ser195 that make up
the catalytic triad, (2) Gly193, Asp194 and Ser195 that form an
oxyanion hole required for catalytic e⁄ciency, (3) Ser214,
Trp215 and Gly216 that bind the main-chain of a substrate,
and (4) residues that occupy the bottom (Ser189) and sides
(Gly216 and Gly226) of the substrate speci¢city pocket (S1 sub-
site). All of the residues contributing to the ¢rst three features
and the residues Gly216 and Gly226 on the sides of the sub-
strate speci¢city pocket of chymotrypsin are strictly conserved
in epitheliasin. However, in epitheliasin the residue corre-
Table 1
Exon^intron junctions organization of epitheliasin gene
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sponding to Ser189 of chymotrypsin is replaced by an acidic
residue, Asp. This suggests that epitheliasin has speci¢city for
cleavage after Lys or Arg, indicating a trypsin-like substrate
speci¢city for the enzyme.
Comparison of the amino acid sequence encoding the pro-
teinase domain in epitheliasin with other serine proteinases
indicates that this region of the protein shares identity with
mouse enteropeptidase (53%), hepsin (51%), acrosin (48%),
and neurotrypsin (46%), all multi-domain members of the
chymotrypsin family of serine proteinases with trypsin-like
substrate speci¢city. The aforementioned CAP 1 from Xeno-
pus laevis kidney epithelial cells has a sequence identity with
epitheliasin of 44%.
Based on ¢ndings with related vertebrate trypsinogens we
predict that epitheliasin is synthesized as an inactive zymogen
that is converted to an active serine proteinase by cleavage of
the Arg253^Ile254 peptide bond in the extracellular domain of
the enzyme. Most vertebrate trypsinogens are activated by
proteolytic cleavage of a Lys (Arg)^Ile bond. The identity
or the origin of the proteinase responsible for this cleavage
in epitheliasin is not known. One possibility is that epithelia-
sin is synthesized as a single-chain zymogen and undergoes
intracellular cleavage and activation by a furin-like enzyme
prior to insertion into the membrane. This is based on the
Arg-Gln-Ser-Arg253 sequence that immediately precedes the
Ile-Val-Gly-Gly257 representing the NH2-terminus of the pro-
teinase domain. Arg-X-X-Arg motifs are furin recognition
sequences [16^20]. Interestingly, all the domains of epithelia-
sin are £anked by recognition sites for furin-like enzymes,
suggesting the need to clarify the role of furin-like enzymes
in processing of epitheliasin.
Based on the structure of enteropeptidase and a comparison
with other chymotrypsin-like serine proteinases, we also pre-
dict that epitheliasin, following intracellular cleavage, forms
two chains with the smaller chain containing the proteinase
domain, and the larger the membrane-spanning segment, and
the LDLRA and SRCR-like domains that may serve as sub-
strate recognition sites. Several chymotrypsin-like serine pro-
teinases including enteropeptidase have a disul¢de bond that
covalently links the two chains [21]. The proteinase domain in
epitheliasin contains eight Cys residues in conserved positions.
By comparison with chymotrypsin, three of the Cys pairs (42/
58, 168/182 and 191/220) that form disul¢de bond loops
around His57, Met180 and Ser195 are conserved in epitheliasin.
Although the other two cysteines (Cys122 and Cys136) are lo-
cated in conserved positions, their pairing counterparts Cys1
and Cys201 that are involved in interchain disul¢de bonds are
absent. This suggests that epitheliasin is likely distinct from
enteropeptidase and other multidomain serine proteinases in
that it lacks disul¢de bond(s) between the proteinase motif
and the rest of the protein [22]. Thus, the mechanism of asso-
ciation of the two chains in epitheliasin is not clear.
Three asparagine-linked glycosylation sites are present in
epitheliasin, Asn111 located at the beginning of the LDLRA
domain of the protein, Asn212 located in the SRCR domain
and Asn474 located in the proteinase domain (see Fig. 1).
Other features of the deduced primary structure of the protein
include a cAMP- or cGMP-dependent protein kinase phos-
phorylation site (Lys249^Ser252). Two protein kinase C phos-
phorylation sites are present in the cytoplasmic domain
(Thr77^Lys79 and Thr80^Lys82), three in the SRCR domain
(Ser162^Arg164, Ser231^Arg233, Ser237^Arg249), one between
the SRCR domain and the proteinase domain (Ser257^
Lys249), and one in the proteinase domain (Thr445^Lys447).
Three casein kinase II phosphorylation sites are present, two
in the LDLRA domain (Ser113^Glu116, Ser116^Glu119), and the
last one in the proteinase domain (Ser261^Asp264). Finally, an
ATP/GTP-binding site motif A is present in the proteinase
domain of epitheliasin, from Ile379 to Ala396. This motif is
found in a number of proteins including those in the myosin
and Ras families. The relevance of these various sites in epi-
theliasin is not presently known.
Fig. 3. Schematic representation of the genomic organization of epitheliasin. The intron placements are depicted in relationship to the domains
of the mouse epitheliasin protein. The numbering represents nucleotides.
Fig. 2. The domain organization of epitheliasin. Starting at the NH2-terminus the epitheliasin contains a TM domain followed by a LDLRA
domain, a SRCR domain, and ¢nally the serine proteinase domain. N-glycosylation sites are indicated by a circle. The numbers in parentheses
refer to the amino acid residues of each domain.
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3.4. Genomic organization
The epitheliasin gene contains 14 exons separated by 13
introns (Fig. 3). The ¢rst exon is located in the 5P untranslated
region. The last exon contains 9 bp of the coding sequence,
the stop codon and the 3P untranslated region. The exon dis-
tribution re£ects the organization of the deduced protein.
Exon 2 and 3, respectively 68 and 220 nt (M1^S78), encode
for the cytoplasmic domain. Exon 4, 87 nt, (K79^F107) encodes
for the transmembrane domain. Exon 5, 117 nt, (D109^R146)
encodes for the LDLR domain (C112^C147). An unusual fea-
ture of epitheliasin is that the SRCR domain is encoded by
three exons, 6^8, respectively 130 nt, 111 and 44 nt (C147^I241).
Usually SRCR domains are encoded by one or two exons, in
regard to type B or type A, respectively. Exons 9^13, respec-
tively 169, 176, 96, 143 and 153 nt, (E242^R490) encode for the
serine protease domain. Vertebrate serine protease-like genes
have been grouped into ¢ve classes based on intron positions
[23]. The gene organization of the epitheliasin protease do-
main is typical of second group containing members of the
trypsin family of serine proteases and consisting of ¢ve exons
with each of the three components of the catalytic triad en-
coded by sequences in a di¡erent exon. In epitheliasin, the
catalytic histidine is located in exon 9, the aspartic in exon
10 and the serine in exon 13. In general, the organization of
epitheliasin is similar to that of other multiple domain serine
proteinases. Each domain is coded in an independent manner
by one or more exons. A common feature among all multi-
domain protease cloned to date is the ¢ve exons coding for
the serine proteinase domain [24].
As shown in Table 1, all intron/exon junctions contain the
expected GT splice donor and AG splice acceptor sites and
conform to the consensus sequences established for intronic
donor and acceptor splice signals [25]. Four introns are in-
serted between codons (type 0 splice junction), ¢ve are after
the ¢rst nucleotide in a codon (type I splice junction), and
four after the second nucleotide codon (type II splice junc-
tion). six bands were strongly positive by Southern analysis
with sizes of 7000, 5000, 2700, 1400, 1200 and 900 nt. Adding
the size of the fragments indicates that the epitheliasin gene is
approximately 18 kb.
3.5. Chromosomal assignment
FISH was performed on normal mouse chromosomes using
a BAC containing the genomic sequence of epitheliasin (Fig.
4). These studies localized the epitheliasin gene to the telomer-
ic region in the long arm of chromosome 16. The band local-
ization was con¢rmed on G-banded chromosomes. The hy-
bridization e⁄ciency was 92.5%. No other serine proteinases
have been localized to this region. The region is homologous
with the so-called ‘Down’s syndrome region’ of human chro-
mosome region 21q22.2 and 21q22.3.
3.6. Expression of epitheliasin mRNA in vivo
The in vivo distribution of epitheliasin mRNA was inves-
tigated in adult mouse tissues by Northern blot analysis. As
shown in Fig. 5, a prominent 2.8 kb transcript and a less
prominent 1.5 kb transcript were observed in the kidney. Be-
cause of preliminary results that suggest an alternative poly-
adenylation site approximately 1.3 kb downstream from the
initial polyadenylation site, we believe that the weaker signal
actually represents the characterized cDNA. A prominent 2.8
kb signal was also seen in the lung and a weaker signal of
similar size was observed in liver tissue. No signal was ob-
served in heart, brain, spleen, testis or skeletal muscle. Of
note, all tissues that express epitheliasin have epithelial cells
as a prominent feature of their cellular makeup.
3.7. Immunohistochemical localization
Fig. 6A shows the kidney in which only tubular epithelial
cells are stained with no staining of glomeruli. The staining is
restricted to cells located in distal tubules. The staining is
most intense at the apical pole of the cells, facing the lumen
of the tubules. The staining is faint in the cytoplasm, basal
and lateral side of the cells. Fig. 6B shows the lung in which
staining is primarily limited to the apical surface of airway
epithelial cells. Staining is minimal or absent in the vascula-
ture and alveolar spaces. No staining was observed in control
slides. Further analysis by in situ hybridization using a 300 nt
epitheliasin riboprobe demonstrated that the pattern of gene
expression was the same as that of protein expression (data
Fig. 5. Northern blot analysis of epitheliasin mRNA in various
mouse tissues. Each lane contained 2 Wg of poly(A)+RNA. The blot
was hybridized to an epitheliasin cDNA probe.
Fig. 4. In situ hybridization of a biotin-labeled epitheliasin probe to
mouse metaphase cells. The chromosome 16 homologues are identi-
¢ed with arrows. Speci¢c labeling was observed at chromosome
band 16C2.
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not shown). These results support the epithelial and mem-
brane localization of epitheliasin.
During the course of this investigation Paolini-Giacobino
and colleagues reported on a human cDNA cloned by exon
trapping named TMPRSS2 [3]. The portion of the TMPRSS2
cDNA that was reported has approximately 80% sequence
identity to epitheliasin. However, the tissue distribution of
epitheliasin and TMPRSS2 is strikingly di¡erent. While epi-
theliasin is highly expressed in the mouse kidney, no expres-
sion of TMPRSS2 was observed in the human kidney. In
contrast, no expression of epitheliasin was observed in the
mouse heart or brain, while a high level of expression of
TMPRSS2 was observed in human heart and an intermediate
level in brain. Moreover, the size of epitheliasin of the mRNA
transcript (2.8 kb) and that of TMPRSS2 (3.8 kb) are di¡er-
ent. Whether TMPRSS2 is the human orthologue of epithe-
liasin or a closely related gene product will require further
study.
The biological role of epitheliasin is not known. The ho-
mology with CAP1 and apical membrane distribution raise
the possibility that epitheliasin may activate ion transport
channels of the plasma membrane. In addition, cell-surface
proteinases of normal and malignant cells are thought to
play roles in cell growth, chemotaxis, endocytosis, exocytosis,
Fig. 6. Immunohistochemical localization of epitheliasin in adult mouse tissue. A: A section from the kidney (magni¢cation 20U). Positive
staining is seen in apical region of renal distal tubule epithelial cells. B: A section from lung (magni¢cation 20U). Positive staining is seen in
bronchial epithelial cells. No stain was observed in control sections in which normal rabbit serum substituted for rabbit anti-mouse epitheliasin
(data not shown).
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blood coagulation, ¢brinolysis and tissue invasion during
metastasis [26]. While the function of the non-proteinase do-
mains is unexplored, the presence of these domains with a
modular organization represents a common feature of regu-
latory serine proteinases (e.g. proteinases of the ¢brinolytic
and blood coagulation systems). Studies of the kinetic e¡ects
of deleting the non-proteinase domain from enteropeptidase
clearly implicate it in the recognition of macromolecular sub-
strates and inhibitors [21].
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